Jakafi 25 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FCZC5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,379
Award facts
- Contract value 100% obligated
- $12,378.73 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) issued a firm fixed-price delivery order valued at $12,378.73 to DMS Pharmaceutical Group Inc. for 60 tablets of Jakafi 25 mg, with a completion date of December 22, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded this delivery order without a set-aside designation, demonstrating its competitive capability in unrestricted federal procurement. The award carries no identified subcontractors and represents a routine pharmaceutical supply transaction for the Department of Defense medical system.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the DLA Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, awarded in November 2025 with a $499.9 billion ceiling and completion date of December 31, 2036. The PPV-G GEN V program is a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical and medical supply support to military healthcare facilities worldwide. As one of multiple regional prime vendor contractors under this framework, DMS Pharmaceutical Group supplies a broad portfolio of branded and generic prescription medications, biologics, vaccines, and medical consumables to support Department of Defense healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26FCZC5?
SPE2DR26FCZC5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 19, 2025.
How much is contract SPE2DR26FCZC5 worth?
The government has obligated $12,379 on SPE2DR26FCZC5.
Is contract SPE2DR26FCZC5 an order under another contract?
Yes. SPE2DR26FCZC5 is a delivery order under SPE2DR25D9127, an indefinite delivery contract.
Was contract SPE2DR26FCZC5 competed?
The extent of competition for SPE2DR26FCZC5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award